Description
DMH2 is a type I bone morphogenetic protein (BMP) receptor inhibitor (Ki values are <1, 5.4 and 43 nM for ALK6, ALK3 and ALK2, respectively). It caused a decrease in cell growth and apoptosis of H1299 non-small cell lung carcinoma cells in vitro